184 related articles for article (PubMed ID: 18473905)
1. The use of proteomics to study infectious diseases.
List EO; Berryman DE; Bower B; Sackmann-Sala L; Gosney E; Ding J; Okada S; Kopchick JJ
Infect Disord Drug Targets; 2008 Mar; 8(1):31-45. PubMed ID: 18473905
[TBL] [Abstract][Full Text] [Related]
2. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
3. A Perspective on Proteomics of Infectious Diseases.
Venkatesh A; Gil C; Fuentes M; LaBaer J; Srivastava S
Proteomics Clin Appl; 2018 Jul; 12(4):e1700139. PubMed ID: 29282898
[TBL] [Abstract][Full Text] [Related]
4. Infectious disorders drug targets--an arsenal of knowledge on pathogen targets.
Tekwani BL
Infect Disord Drug Targets; 2008 Mar; 8(1):46-7. PubMed ID: 18473906
[No Abstract] [Full Text] [Related]
5. High throughput genomic and proteomic technologies in the fight against infectious diseases.
Tanca A; Deligios M; Addis MF; Uzzau S
J Infect Dev Ctries; 2013 Mar; 7(3):182-90. PubMed ID: 23492995
[TBL] [Abstract][Full Text] [Related]
6. Yeast genomics and proteomics in drug discovery and target validation.
Parsons AB; Geyer R; Hughes TR; Boone C
Prog Cell Cycle Res; 2003; 5():159-66. PubMed ID: 14593709
[TBL] [Abstract][Full Text] [Related]
7. Identification of anti-infective targets through comparative proteomics.
Burchmore R
Expert Rev Anti Infect Ther; 2006 Apr; 4(2):163-5. PubMed ID: 16597196
[No Abstract] [Full Text] [Related]
8. The impact of genomics on discovering drugs against infectious diseases.
Boshoff HI; Manjunatha UH
Microbes Infect; 2006 May; 8(6):1654-61. PubMed ID: 16690340
[TBL] [Abstract][Full Text] [Related]
9. [Infectious diseases--new horizons].
Spirer Z; Barzilai A
Harefuah; 2012 Aug; 151(8):483-7, 496. PubMed ID: 23350296
[TBL] [Abstract][Full Text] [Related]
10. Proteomic studies in plants.
Park OK
J Biochem Mol Biol; 2004 Jan; 37(1):133-8. PubMed ID: 14761311
[TBL] [Abstract][Full Text] [Related]
11. Genomics and proteomics tools for compound mode-of-action studies in drug discovery.
Kley N; Ivanov I; Meier-Ewert S
Pharmacogenomics; 2004 Jun; 5(4):395-404. PubMed ID: 15165175
[TBL] [Abstract][Full Text] [Related]
12. Proteomic technology and its biomedical applications.
Lau AT; He QY; Chiu JF
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Nov; 35(11):965-75. PubMed ID: 14614532
[TBL] [Abstract][Full Text] [Related]
13. Genomics, systems biology and drug development for infectious diseases.
Sakata T; Winzeler EA
Mol Biosyst; 2007 Dec; 3(12):841-8. PubMed ID: 18000561
[TBL] [Abstract][Full Text] [Related]
14. Proteomics in veterinary medicine: applications and trends in disease pathogenesis and diagnostics.
Ceciliani F; Eckersall D; Burchmore R; Lecchi C
Vet Pathol; 2014 Mar; 51(2):351-62. PubMed ID: 24045891
[TBL] [Abstract][Full Text] [Related]
15. What was old is new again: using the host response to diagnose infectious disease.
Ko ER; Yang WE; McClain MT; Woods CW; Ginsburg GS; Tsalik EL
Expert Rev Mol Diagn; 2015; 15(9):1143-58. PubMed ID: 26145249
[TBL] [Abstract][Full Text] [Related]
16. Trends in biomedical engineering: focus on Genomics and Proteomics.
Pattini L; Bertacco R; Candiani G; Masseroli M; Servi S
J Appl Biomater Biomech; 2011; 9(2):98-108. PubMed ID: 22065387
[TBL] [Abstract][Full Text] [Related]
17. Human defensins: turning defense into offense?
de Leeuw E; Lu W
Infect Disord Drug Targets; 2007 Mar; 7(1):67-70. PubMed ID: 17346213
[TBL] [Abstract][Full Text] [Related]
18. The role of medical structural genomics in discovering new drugs for infectious diseases.
Van Voorhis WC; Hol WG; Myler PJ; Stewart LJ
PLoS Comput Biol; 2009 Oct; 5(10):e1000530. PubMed ID: 19855826
[No Abstract] [Full Text] [Related]
19. Host-directed drug targeting of factors hijacked by pathogens.
Schwegmann A; Brombacher F
Sci Signal; 2008 Jul; 1(29):re8. PubMed ID: 18648074
[TBL] [Abstract][Full Text] [Related]
20. Observational, hypothesis-driven and genomics research strategies for analyzing inherited differences in responses to infectious diseases.
Allison AC
Public Health Genomics; 2009; 12(1):41-52. PubMed ID: 22543957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
